Regeneron Pharmaceuticals Inc (REGN) — Long-term Investment Intensity
Regeneron Pharmaceuticals Inc (REGN) has a Long-term Investment Intensity of 23.6% as of June 2026. Long-term investments of $9.83 Billion represent 23.6% of total assets of $41.73 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Regeneron Pharmaceuticals Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Regeneron Pharmaceuticals Inc Long-term Investment Intensity (2010–2025)
This chart shows how Regeneron Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 12 annual periods from 2010 to 2025. As of June 2026, the intensity stands at 23.6%, reflecting long-term investments of $9.83 Billion against total assets of $41.73 Billion USD. For the complete balance sheet picture, see Regeneron Pharmaceuticals Inc asset portfolio.
Annual Long-term Investment Intensity for Regeneron Pharmaceuticals Inc (2010–2025)
The table below presents the year-by-year Long-term Investment Intensity for Regeneron Pharmaceuticals Inc from 2010 to 2025, covering 12 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Regeneron Pharmaceuticals Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 25.3% | $10.26 Billion | $40.56 Billion | ▲ +1.7 pp |
| 2024 | 23.6% | $8.90 Billion | $37.76 Billion | ▲ +7.3 pp |
| 2023 | 16.3% | $5.40 Billion | $33.08 Billion | ▼ -6.3 pp |
| 2022 | 22.6% | $6.59 Billion | $29.21 Billion | ▼ -4.3 pp |
| 2021 | 26.9% | $6.84 Billion | $25.43 Billion | ▲ +8.6 pp |
| 2020 | 18.3% | $3.14 Billion | $17.16 Billion | ▼ -3.7 pp |
| 2019 | 22.0% | $3.26 Billion | $14.81 Billion | ▲ +7.0 pp |
| 2018 | 15.0% | $1.75 Billion | $11.73 Billion | ▼ -2.0 pp |
| 2017 | 17.0% | $1.49 Billion | $8.76 Billion | ▲ +4.6 pp |
| 2016 | 12.4% | $864.26 Million | $6.97 Billion | ▼ -8.5 pp |
| 2011 | 20.8% | $275.89 Million | $1.32 Billion | ▼ -13.1 pp |
| 2010 | 34.0% | $370.05 Million | $1.09 Billion | — |